+ Watch AEZS
on My Watchlist
A growing global biopharmaceutical company focused on endrocrine therapy and oncology, in drug discovery, development and commercialization.
How far do you think this stock can Drop ??
How far can it drop? all the way.. how far will it drop? the answer depends entirely upon how many people are playing this position solely as day-traders with no real interest in the value of the company at large. Aeterna states... "Although the FDA's decision will not allow us to submit our New Drug Application on a rolling basis, it should not affect the timing of our filing of the NDA for AEZS-130, which is expected early next year, nor should it affect the potential of obtaining priority review." on this news alone the price cut 20%, in simple terms, "because people didnt want to potentially wait for a breakout FDA decision" (shrug).. for the record, I value conservatively at 1.10/share despite the more (seemingly obscene recent valuation at 1.78 prior to any FDA headnods)(shrug).. what do i know.. Consider my Caps score, <20. I dont mind saying, or almost bragging that these type of predictible stock-swings based on time sensative "updates", have played very well for my future as a "swing trader", -Cents Wolf
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions